1. Technology Overview

The invention focuses on thiol-triggered sulfenyl thiocarbonates and sulfenyl thiocarbamates that release carbonyl sulfide (COS) and hydrogen sulfide (H2S) in the presence of biologically relevant thiols. These compounds offer a concomitant fluorescence response, providing optical indication of COS and H2S release. The technology is currently in the development stage, with promising cross-industry applications in biological detection, imaging, and targeted drug delivery.

2. Key Features and Benefits

• Fluorescence response: Provides optical indication of COS/H2S release.
• Diversifiable releasing group: Enables conjugation to various fluorophores and drug molecules.
• Versatility: Applicable to various industries, including biotechnology and pharmaceuticals.
• Scalability: Synthesis processes can be scaled for larger quantities.
• Targeted applications: Ideal for biological detection, imaging, and drug delivery systems.

3. Applications and Market Focus

• Biological detection: Use in detecting and imaging biological processes involving COS/H2S.
• Drug delivery: Integration into targeted drug delivery systems.
• Biotechnology: Development of novel biological detection and imaging methods.
• Pharmaceutical industry: Synthesis of complex organic molecules for various applications.
• Chemical industry: Use in advanced synthesis techniques and equipment.

4. Commercial Advantages

• Strategic benefits: Provides reliable and scalable COS/H2S releasing compounds for various applications.
• Implementation advantages: Facilitates integration into existing biological detection and imaging systems.
• Market positioning: Positions technology as a key enabler for advanced biological detection and drug delivery systems.
• Competitive advantages: Offers fluorescence response and diversifiable releasing group compared to existing methods.

5. Partnership Opportunities

• Ideal licensing partners: Biotechnology firms, pharmaceutical companies, chemical industry leaders.
• Cross-sector partnership benefits: Collaboration opportunities across biotechnology and pharmaceutical industries.
• Diverse market opportunities: Potential for global market expansion in regions with strong biotechnology and pharmaceutical industries.
• Collaborative development: Opportunities for joint development of hybrid devices and custom synthesis services.